This month we highlight the possibility that the Supreme Court
will consider the standard for adequacy of written description and
a Federal Circuit exposition on the relationship between
"blocking patents" and objective indicia of
nonobviousness.
CASES
Supreme Court
Written Description at the Supreme Court?
Amgen, Inc. v. Sanofi (cert.
petition)
On September 18, the Supreme Court requested a brief responding
to Amgen's cert. petition. The question presented by Amgen is:
"Whether the standard for determining the adequacy of the
"written description of the invention" should be as the
statute says—that the description must be "in such full,
clear, concise, and exact terms as to enable any person skilled in
the art to which it pertains . . . to make and use the same"
— or whether court-created standards should control
instead."